Top Small Cap Stocks To Follow Now - August 13th

Key Points

• BitMine Immersion Technologies (BMNR) recently traded down to $61.70, with a market cap of $265.50 million and a significant price-to-earnings ratio of -140.23.
• Bolt Projects (BSLK) saw a notable increase in stock price, trading up to $13.96, marked by a substantial volume of 245,477,029 shares exchanged on that day.
• 180 Life Sciences (ATNF), focusing on therapeutics for chronic pain and inflammation, reached $10.53 with a market cap of $63.57 million, despite a losses reflected in its price-to-earnings ratio of -0.71.

BitMine Immersion Technologies, Bolt Projects, and 180 Life Sciences are the three Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of publicly traded companies with a market capitalization generally between about $300 million and $2 billion. Because these firms are smaller and less established than mid- or large-caps, their shares tend to offer higher growth potential but also come with greater price volatility and liquidity risk. Investors in small caps may gain from early exposure to emerging businesses, though they should be prepared for wider swings in value. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

BitMine Immersion Technologies (BMNR)

BitMine Immersion Technologies, Inc. is a financial services company in the Banking industry.

BMNR stock traded down $0.74 during trading on Wednesday, reaching $61.70. 95,572,905 shares of the company were exchanged, compared to its average volume of 10,461,278. The stock has a market cap of $265.50 million and a price-to-earnings ratio of -140.23. BitMine Immersion Technologies has a twelve month low of $1.93 and a twelve month high of $161.00.

Read Our Latest Research Report on BMNR

Bolt Projects (BSLK)

BSLK stock traded up $11.78 during trading on Wednesday, reaching $13.96. 245,477,029 shares of the company were exchanged, compared to its average volume of 2,684,943. The company has a 50-day moving average of $2.52 and a two-hundred day moving average of $5.05. Bolt Projects has a twelve month low of $1.75 and a twelve month high of $199.60.

Read Our Latest Research Report on BSLK

180 Life Sciences (ATNF)

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor.

ATNF stock traded up $0.29 during trading on Wednesday, reaching $10.53. 81,636,053 shares of the company were exchanged, compared to its average volume of 3,129,264. The company has a 50-day moving average of $1.82 and a two-hundred day moving average of $1.35. The company has a market capitalization of $63.57 million, a price-to-earnings ratio of -0.71 and a beta of 0.38. 180 Life Sciences has a twelve month low of $0.66 and a twelve month high of $17.75.

Read Our Latest Research Report on ATNF

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.